OEL
职业接触限值数据库
托莫西汀
Atomoxetine
(R)-N-甲基-3-(2-甲基苯氧基)苯丙胺, Hismanal(R), [3H]-Astemizole, MFCD00865352, benzenepropanamine, N-methyl-g-(2-methylphenoxy)-, (gR)-, Laridal, (3R)-N-Methyl-3-(2-methylphenoxy)-3-phenyl-1-propanamine, Histaminos, astemizole, 1-[(4-fluorophenyl)methyl]-N-[1-[2-(4-methoxyphenyl)ethyl]-4-piperidinyl]-1H-benzimidazole-2-amine, Paralergin, (gR)-N-Methyl-g-(2-methylphenoxy)benzenepropanamine, tomoxetine [INN_en], 1-(4-fluorophenylmethyl)-N-{1-[2-(4-methoxyphenyl)ethyl]-4-piperidinyl}-1H-benzimidazol-2-amine, [14C]-Atomoxetine, (R)-N-methyl-3-(2-tolyloxy)-3-(phenyl)propylamine, (-)-Tomoxetine, Tomoxetine [INN], Retolen, Alermizol, [14C]-Astemizole, (R)-Tomoxetine, (3R)-N-methyl-3-(2-methylphenoxy)-3-phenylpropan-1-amine, Atomoxetine, Astemison, Astemizolum, Benzenepropanamine, N-methyl-γ-(2-methylphenoxy)-, (γR)-, Astemizol, Hismanal
CAS号: 83015-26-3
SMILES: CC1=CC=CC=C1O[C@H](CCNC)C2=CC=CC=C2
EC号: 617-427-9
免责声明 Disclaimer
1. CIRS努力保证内容的准确性并及时更新。但是，CIRS不对信息的质量、准确性、完整性或可靠性负责。
2. 在任何时候，CIRS不对因用户使用本数据库的信息导致的任何声明、损害或者损失负责以及承担责任。
3. CIRS保留在没有事先通知的情况下进行修改、修正、增加或者移除部分信息的权利。
